Clinical Trials Browser

INDUSTRY × Patient Preference × Clear all

Breast Neoplasms, Patient Preference, Inflammatory Breast Neoplasms

NCT06125795 2026-01-12

PROVIDENCE

Recruiting

132 enrolled

LymphoidOther hematologic neoplasm

Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Patient Preference

NCT06101134 2025-04-14

A Study to Evaluate Whether Participants With Melanoma Prefer Subcutaneous vs Intravenous Administration of Nivolumab and Nivolumab + Relatlimab Fixed-dose Combinations

Phase 2 Active not recruiting

100 enrolled

Dermatologic

Melanoma, Neoplasm Metastasis, Patient Preference

NCT05883956 2025-03-20

PREFER-HMA

Phase 3 Active not recruiting

13 enrolled

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Patient Preference

NCT05284591 2024-10-01

MYLENE

Completed

96 enrolled

Plasma cell

Multiple Myeloma, Personal Satisfaction, Patient Satisfaction, Patient Preference

NCT05115006 2022-06-30

A Study of Adjuvant Melanoma Stakeholder Treatment Preferences

Completed

294 enrolled

Dermatologic

Melanoma, Patient Preference

NCT01064310 2017-04-17

PISCES

Phase 3 Completed

169 enrolled 16 charts

Genitourinary

Carcinoma, Renal Cell, Neoplasms, Patient Preference

NCT00721981 2010-12-10

An Evaluation of the Clinical Treatment and Patient Values and Preferences of Patients Suffering From Advanced Non-small Cell Lung Cancer (NSCLC) Undergoing Chemotherapy

Terminated

120 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms, Patient Preference

Clinical Trials

ProHer